Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-specific skin cellular and extracellular components refer to the collective biological structures of the human skin, including the epidermis, dermis, and the associated extracellular matrix (ECM) (Kanitakis, 2002). This category is not a single molecular target but rather a complex tissue environment consisting of various cell types like keratinocytes and fibroblasts, along with structural proteins such as collagen and elastin (Frantz et al., 2010). In pharmacology, these components serve as the site of action for a wide range of topical agents that do not necessarily bind to a specific receptor (Madison, 2003). For instance, emollients and humectants target the stratum corneum to restore barrier integrity and improve hydration through physical occlusion or osmotic effects (Yousef et al., 2022). Similarly, physical sunscreens like zinc oxide interact with the skin surface to reflect or scatter ultraviolet radiation, protecting the underlying cellular DNA (StatPearls, 2023). Because this 'target' encompasses a broad array of structural and cellular elements, it is typically used as a descriptive term for drugs with non-specific or multi-faceted mechanisms of action within the skin. Therapeutic interventions targeting these components are essential for managing conditions such as dermatitis, xerosis, and skin aging, where the goal is to restore the integrity of the cutaneous barrier (PubMed, 2021). Overall, while not a discrete protein or enzyme, these components are fundamental to maintaining cutaneous homeostasis and defending against environmental insults.
Drugs targeting these components act through various non-specific mechanisms, including physical occlusion to prevent transepidermal water loss, humectancy to attract moisture into the stratum corneum, and the physical reflection or absorption of ultraviolet radiation (Madison, 2003; Yousef et al., 2022).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific skin cellular and extracellular components.